Search

PROCEPT BioRobotics Corp

Slēgts

SektorsVeselības aprūpe

20.65 0.34

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

20.59

Max

20.84

Galvenie mērījumi

By Trading Economics

Ienākumi

-27M

-58M

Pārdošana

11M

94M

EPS

-0.47

Peļņas marža

-61.905

Darbinieki

888

EBITDA

5.1M

-24M

Rekomendācijas

By TipRanks

Rekomendācijas

Neitrāls

Prognoze 12 mēnešiem

+11.04% upside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 3. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

171M

1.2B

Iepriekšējā atvēršanas cena

20.31

Iepriekšējā slēgšanas cena

20.65

Ziņu noskaņojums

By Acuity

50%

50%

126 / 340 Rangs Healthcare

PROCEPT BioRobotics Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 28. aug. 19:46 UTC

Procept Biorobotics Corp shares are higher since Thursday's close, despite earlier declines during the session. No specific news was identified for today's movement.

2026. g. 26. aug. 19:26 UTC

News

Procept Biorobotics faces a class action lawsuit alleging securities fraud related to inflated handpiece sales, contributing to a decline in shares during Wednesday's session.

2026. g. 25. aug. 19:46 UTC

Procept Biorobotics shares are higher today amid favorable market conditions, including lower crude oil prices and decreasing Treasury yields. No specific company news was identified.

2026. g. 24. aug. 19:36 UTC

News

Procept Biorobotics faces multiple class action lawsuits alleging securities fraud, contributing to negative sentiment as shares trade lower today.

2026. g. 21. aug. 23:26 UTC

Procept Biorobotics shares are higher in after-market trading, amid a broader market recovery following recent geopolitical tensions and their impact on energy prices.

2026. g. 20. aug. 20:06 UTC

News

Shares of Procept Biorobotics Corp are lower following a class action lawsuit alleging false sales and revenue statements, impacting investor sentiment amid negative earnings reports.

2026. g. 19. aug. 19:26 UTC

News

Procept Biorobotics faces a class action lawsuit from Kaplan Fox & Kilsheimer LLP but shares are trading higher during Wednesday's session.

2026. g. 18. aug. 19:16 UTC

Procept Biorobotics Corp shares are higher, trading near the upper end of their one-month range, despite pulling back from earlier session highs.

2026. g. 17. aug. 19:56 UTC

News

Procept Biorobotics faces downward pressure amid class action lawsuits alleging securities fraud, contributing to negative sentiment and a decline since Friday's close.

2026. g. 14. aug. 19:46 UTC

News

Procept Biorobotics faces class action lawsuits alleging securities fraud, leading shares to decline during Friday's session after earlier reaching a high.

2026. g. 13. aug. 20:06 UTC

Procept Biorobotics Corp is gaining during Thursday's session, following strong momentum and peaking at 7.26% earlier, despite a pullback in recent trading.

2026. g. 12. aug. 20:01 UTC

News

Procept Biorobotics shares are lower amid a class action lawsuit alleging securities fraud related to undisclosed inventory issues and misleading sales practices.

2026. g. 11. aug. 20:02 UTC

Procept Biorobotics Corp shares are higher today, marking the seventh consecutive session of gains. No specific news was identified to explain the increase.

2026. g. 10. aug. 19:53 UTC

Procept Biorobotics Corp shares are higher, supported by reduced Fed rate hike expectations following Friday's weaker jobs report. The stock remains above its 20-day moving average.

2026. g. 7. aug. 20:02 UTC

News

Procept Biorobotics shares are higher as analysts adjust ratings; Wells Fargo sets target at $19.00, while UBS downgrades to "neutral" with a $20.00 target.

2026. g. 6. aug. 20:03 UTC

Procept Biorobotics shares are higher Thursday, recovering from an earlier decline. The stock closed above its 20-day moving average amid broader market dynamics.

2026. g. 5. aug. 19:52 UTC

News

Procept Biorobotics shares are higher as TD Cowen maintains a Buy rating and Piper Sandler reiterates its Overweight rating amid increased investor engagement.

2026. g. 4. aug. 23:02 UTC

News

Procept Biorobotics reported a second-quarter loss of $26.9 million and shares are trading lower in after-market hours following the earnings report.

2026. g. 3. aug. 20:03 UTC

News

Procept Biorobotics shares decline amid a securities class action lawsuit alleging financial misrepresentation through inflated sales and excess inventory.

2026. g. 31. jūl. 20:02 UTC

News

Procept Biorobotics shares are rising today, even after UBS downgraded its rating to neutral with a $20 price target.

2026. g. 30. jūl. 19:58 UTC

Procept Biorobotics Corp is rising during Thursday's session, driven by a broader market rally and recovery in technology shares. No specific company news was identified.

2026. g. 29. jūl. 16:26 UTC

Procept Biorobotics Corp shares are higher Wednesday, recovering from earlier losses amid broader market volatility ahead of the Federal Reserve's interest rate decision.

2026. g. 28. jūl. 19:26 UTC

Procept Biorobotics Corp shares are trading higher, reflecting a cumulative gain since Monday, despite negative sentiment from declines in Asian markets.

2026. g. 27. jūl. 17:02 UTC

News

Procept Biorobotics reported Q1 revenue of $83.1 million, a 20% increase. Shares are trading higher, recovering from recent declines since Friday's close.

2026. g. 22. jūl. 19:41 UTC

Procept Biorobotics Corp shares are lower today, diverging from recent gains. Broader market concerns include rising crude oil prices and inflationary pressures.

2026. g. 21. jūl. 16:01 UTC

Procept Biorobotics Corp is declining during Tuesday's session, breaking a trend of higher daily closes. No specific news was identified for the move.

2026. g. 20. jūl. 19:56 UTC

Procept Biorobotics Corp shares are higher today, despite earlier volatility and no specific news. Broader market performance remains mixed amid geopolitical tensions.

Salīdzinājums

Cenas izmaiņa

PROCEPT BioRobotics Corp Prognoze

Cenas mērķis

By TipRanks

11.04% augšup

Prognoze 12 mēnešiem

Vidējais 23.13 USD  11.04%

Augstākais 29 USD

Zemākais 19 USD

Pamatojoties uz 11 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi PROCEPT BioRobotics Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

11 ratings

3

Pirkt

7

Turēt

1

Pārdot

Noskaņojums

By Acuity

126 / 340 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
help-icon Live chat